Skip to content

Upcoming December 2012 – January 2013 FDA Advisory Committee Meetings Involving Orphan Drugs

December 7, 2012

       Here is a list of December 2012 – January 2013 FDA Advisory Committee (AdComm) Meetings involving orphan drugs. (Please contact the Orphan Druganaut Blog, orphandruganaut@gmail.com, if the reader is aware of any updates) :  

1) December 20, 2012: Arthritis Advisory Committee Meeting to “discuss New Drug Application (NDA) 22151, rintatolimod injection (proposed trade name Ampligen) submitted by Hemispherx Biopharma, Inc, for the treatment of patients with Chronic Fatigue Syndrome”.  

2) January 30, 2013: Pulmonary-Allergy Drugs Advisory Committee Meeting to “discuss the New Drug Application (NDA) 202049, for mannitol inhalation powder (proposed trade name Bronchitol) for oral inhalation sponsored by Pharmaxis, for the proposed indication of management of Cystic Fibrosis (CF) in patients aged 6 years and older to improve pulmonary function”. 

References 

FDA 2012 Advisory Committee Tentative Meetings as of 12/03/2012  

FDA 2012 – 2013 Advisory Committee Calendar as of 12/07/2012  

Copyright © 2012-2013, Orphan Druganaut Blog.  All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: